Full coverage· Health· Updated
Weizmann Institute Discovers Viagra’s Potential to Extend Cancer Patients’ Lives
The Weizmann Institute found that Viagra can inhibit cancer metastasis by altering cholesterol metabolism, improving survival rates especially with statins. This discovery was supported by lab studies and patient data from Clalit.
4 newsrooms · 1 language · since
Plus
What happened
- 01Weizmann researchers discovered Viagra’s active ingredient disrupts cancer cell cholesterol metabolism, hindering metastasis.
- 02Cancer patients using Viagra showed significantly higher survival rates, enhanced further by statins.
- 03Polypid signed a deal with Azurity to market its D-PLEX surgical infection prevention product in North America.
- 04The Technion is part of a $35 million project developing AI MRI tools for early ovarian cancer detection.
- 05Dr. Julie E. Elie won a $100,000 prize for decoding zebra finch bird communication.
- 06Polypid’s CEO highlighted Azurity’s hospital presence and development plans as key to the partnership.
Meanwhile, Polypid partnered with Azurity to market a surgical infection prevention product, and Technion researchers joined a major ovarian cancer early detection project.
The coverage
4 newsrooms on this story
Who covered it
- LeftNone
- Centre3
- RightNone
- HarediNone
- ArabNone
- Other1
How it broke
See which of the 4 newsrooms broke it, and who waited